Using unbiased protein interactomics screening and molecular validation, we found that TRIM56 directly interacted with FASN, a key lipogenesis factor driving hepatic steatosis in NAFLD/NASH. The gene discussed is TRIM56; the disease is metabolic dysfunction-associated steatotic liver disease.